logo-loader
viewCadence Minerals PLC

Cadence Minerals investee company Macarthur Minerals confirms lithium mineralisation at Tambourah Project in Western Australia

Kiran Morzaria, Cadence’s chief executive officer, commented: "This is an exciting discovery of a mineralized pegmatite containing up to 1.47% Li2O, showing excellent potential for lithium"

Lithium
Cadence has a 15.2% equity interest in Macarthur, which is an Australian mining exploration company

Cadence Minerals PLC (LON:KDNC) has told shareholders that investee company Macarthur Minerals Limited (TSX-V:MMS) has confirmed lithium mineralisation at the Tambourah Lithium Project in the Pilbara region of Western Australia, with rock chip assay results of up to 1.47% Li2O.

Kiran Morzaria, Cadence’s chief executive officer, commented: "This is an exciting discovery of a mineralized pegmatite containing up to 1.47% Li2O, showing excellent potential for lithium."

READ: Cadence Minerals says Yangibana Rare Earth Project operator sees 21 million tonnes of resources for 2017

He added: “Macarthur Minerals will be undertaking further geochemical sampling to discover additional pegmatites that host lithium and we look forward to future developments on this prospect."

Cadence has a 15.2% equity interest in Macarthur, which is an Australian mining exploration company focused primarily on lithium, iron ore and gold in the Pilbara region and a lithium project in Nevada, USA.

Quick facts: Cadence Minerals PLC

Price: 4.7 GBX

AIM:KDNC
Market: AIM
Market Cap: £4.96 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Symphony Environmental Technologies has game changing...

Symphony Environmental Technologies PLC (AIM: SYM) CEO Michael Laurier joined Steve Darling from Proactive with news the company has received U.S. Food & Drugs Administration approval or its d2p antimicrobial technology. Laurier discusses what that means for the company and what their...

5 hours, 48 minutes ago

2 min read